New Edge Advisors, LLC Biotechnology

New Edge Advisors, LLC

$16 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CUE Cue Biopharma, Inc.	$26.9M	$2,000 0.0% of portfolio	2,550	Q2 2024 New
PCVX Vaxcyte, Inc.	$1.8B	$2,000 0.0% of portfolio	29	Q4 2023 New
APLS Apellis Pharmaceuticals, Inc.	$1.98B	$1,000 0.0% of portfolio	50	Q2 2024 Reduced 77.88%
AUPH Aurinia Pharmaceuticals Inc.	$1.1B	$1,000 0.0% of portfolio	207	Q4 2024 Reduced 79.46%
CPRX Catalyst Pharmaceuticals, Inc.	$2.32B	$1,000 0.0% of portfolio	55	Q4 2024 New
EDIT Editas Medicine, Inc.	$88M	$1,000 0.0% of portfolio	1,295	Q4 2024 Reduced 13.95%
TSVT 2seventy Bio, Inc.	$189M	$0 0.0% of portfolio	195	Q1 2024 Added 4.84%
ABCL Ab Cellera Biologics Inc.	$699M	$0 0.0% of portfolio	300	Q3 2024 Reduced 50.0%
ABEO Abeona Therapeutics Inc.	$28.8M	$0 0.0% of portfolio	1	Q3 2024 New
ADPT Adaptive Biotechnologies Corp	$1.05B	$0 0.0% of portfolio	45	Q1 2024 Reduced 99.55%
ALEC Alector, Inc.	$76M	$0 0.0% of portfolio	32	Q2 2023 Reduced 65.22%
ALLK Allakos Inc.	$28M	$0 0.0% of portfolio	47	Q4 2023 New
ARCT Arcturus Therapeutics Holdings Inc.	$280M	$0 0.0% of portfolio	26	Q4 2022 New
BGNE Bei Gene, Ltd.	$23.5B	$0 0.0% of portfolio	1	Q2 2024 Reduced 87.5%
BCRX Biocryst Pharmaceuticals Inc	$1.38B	$0 0.0% of portfolio	11	Q4 2024 New
BLRX Bio Line Rx Ltd.	$177M	$0 0.0% of portfolio	4,300	Q4 2022 New
BTAI Bio Xcel Therapeutics, Inc.	$48.8M	$0 0.0% of portfolio	500	Q3 2023 Reduced 75.0%
BPMC Blueprint Medicines Corp	$5.03B	$0 0.0% of portfolio	4	Q4 2022 New
CRDF Cardiff Oncology, Inc.	$124M	$0 0.0% of portfolio	81	Q4 2022 New
CVM Cel Sci Corp	$10.8M	$0 0.0% of portfolio	801	Q4 2024 Added 0.13%
CVAC Cure Vac N.V.	$602M	$0 0.0% of portfolio	129	Q3 2023 Reduced 3.01%
EWTX Edgewise Therapeutics, Inc.	$850M	$0 0.0% of portfolio	9	Q2 2024 New
GLPG Galapagos Nv	$1.62B	$0 0.0% of portfolio	6	Q3 2024 Reduced 57.14%
GERN Geron Corp	$480M	$0 0.0% of portfolio	1	Q4 2024 New
HUMA Humacyte, Inc.	$173M	$0 0.0% of portfolio	50	Q3 2024 New
IMTX Immatics N.V.	$325M	$0 0.0% of portfolio	104	Q1 2024 New
IBRX Immunity Bio, Inc.	$989M	$0 0.0% of portfolio	351	Q4 2024 Added 0.29%
LXRX Lexicon Pharmaceuticals, Inc.	$96.3M	$0 0.0% of portfolio	5	Q4 2024 New
MNKD Mannkind Corp	$1.17B	$0 0.0% of portfolio	100	Q2 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$233M	$0 0.0% of portfolio	57	Q2 2024 Reduced 86.4%
MNOV Medicinova Inc	$71.1M	$0 0.0% of portfolio	3	Q4 2024 New
OCGN Ocugen, Inc.	$147M	$0 0.0% of portfolio	4	Q4 2024 New
PMCB Pharma Cyte Biotech, Inc.	$24.7M	$0 0.0% of portfolio	2	Q2 2024 Reduced 33.33%
PYXS Pyxis Oncology, Inc.	$33.7M	$0 0.0% of portfolio	250	Q4 2023 Reduced 86.05%
RVMD Revolution Medicines, Inc.	$3.22B	$0 0.0% of portfolio	21	Q1 2023 Reduced 78.13%
SABSW Sab Biotherapeutics Inc Wt Exp	$0	$0 0.0% of portfolio	1,072	Q4 2022 New
SPRO Spero Therapeutics, Inc.	$26.3M	$0 0.0% of portfolio	100	Q4 2022 New
VXRT Vaxart, Inc.	$43M	$0 0.0% of portfolio	1	Q4 2024 Reduced 99.77%
VCYT Veracyte, Inc.	$2.23B	$0 0.0% of portfolio	2	Q3 2024 Reduced 90.48%
VIR Vir Biotechnology, Inc.	$744M	$0 0.0% of portfolio	20	Q3 2024 New
BDTX Black Diamond Therapeutics, Inc.	$52.3M	$0 0.0% of portfolio	17	Q1 2023 Reduced 84.96%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.